Why Is GlycoMimetics (GLYC) Stock Down 77% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

GlycoMimetics stock is falling on Monday with heavy trading of GLYC after posting lackluster results from a Phase 3 trial of uproleselan.

The post Why Is GlycoMimetics (GLYC) Stock Down 77% Today? appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”